Finance · Search · Sign in · Sign up

Melaine sells SCTY 50.65: Genomic Health's Oncotype DX Redefines Breast Cancer Therapy - Analyst Blog


Recently, a clinical decision impact study presented at the American Society of Clinical Oncology (ASCO) revealed that the Oncotype DX DCIS Score results have changed treatment recommendations for 1 out of 3 patients with DCIS, highlighting the need for .. ...


21 people liked this



See more

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home